Cite
Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
MLA
Gerstein, Hc, et al. Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Jan. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........c7aeb76467c91e11c8781f0aa9e68ad0&authtype=sso&custid=ns315887.
APA
Gerstein, H., Ratner, R., Cannon, C., Serruys, P. (Patrick), Garcia Garcia, H., Es, G., Kolatkar, N., Kravitz, B., Miller, D., Huang, C., Fitzgerald, P., & Nesto, R. (2010). Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Chicago
Gerstein, Hc, Re Ratner, Cp Cannon, PWJC (Patrick) Serruys, Hector Garcia Garcia, Gerrit-anne Es, Ns Kolatkar, et al. 2010. “Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.narcis........c7aeb76467c91e11c8781f0aa9e68ad0&authtype=sso&custid=ns315887.